Moreover, they found that decreased ORC6 expression sensitized human colorectal cell lines to 5-fluorouracil and cisplatin, and thus, ORC6 may be a novel therapeutic target in colon cancer 69. This evidence concerns the gene ORC6 and malignant colon neoplasm.